nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Ototoxicity—Furosemide—dilated cardiomyopathy	0.0532	0.0532	CcSEcCtD
Tobramycin—Instillation site pain—Furosemide—dilated cardiomyopathy	0.0328	0.0328	CcSEcCtD
Tobramycin—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.0298	0.0298	CcSEcCtD
Tobramycin—Application site pain—Furosemide—dilated cardiomyopathy	0.0243	0.0243	CcSEcCtD
Tobramycin—Local reaction—Furosemide—dilated cardiomyopathy	0.0193	0.0193	CcSEcCtD
Tobramycin—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0168	0.0168	CcSEcCtD
Tobramycin—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.0158	0.0158	CcSEcCtD
Tobramycin—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0154	0.0154	CcSEcCtD
Tobramycin—Lethargy—Spironolactone—dilated cardiomyopathy	0.0145	0.0145	CcSEcCtD
Tobramycin—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.014	0.014	CcSEcCtD
Tobramycin—Injection site pain—Furosemide—dilated cardiomyopathy	0.0131	0.0131	CcSEcCtD
Tobramycin—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.013	0.013	CcSEcCtD
Tobramycin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0122	0.0122	CcSEcCtD
Tobramycin—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0117	0.0117	CcSEcCtD
Tobramycin—Drug interaction—Furosemide—dilated cardiomyopathy	0.0115	0.0115	CcSEcCtD
Tobramycin—Hearing impaired—Furosemide—dilated cardiomyopathy	0.0112	0.0112	CcSEcCtD
Tobramycin—Laryngitis—Lisinopril—dilated cardiomyopathy	0.0111	0.0111	CcSEcCtD
Tobramycin—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.0108	0.0108	CcSEcCtD
Tobramycin—Renal failure—Spironolactone—dilated cardiomyopathy	0.0108	0.0108	CcSEcCtD
Tobramycin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0103	0.0103	CcSEcCtD
Tobramycin—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00912	0.00912	CcSEcCtD
Tobramycin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00906	0.00906	CcSEcCtD
Tobramycin—Protein urine present—Lisinopril—dilated cardiomyopathy	0.009	0.009	CcSEcCtD
Tobramycin—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00896	0.00896	CcSEcCtD
Tobramycin—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00882	0.00882	CcSEcCtD
Tobramycin—Swelling—Furosemide—dilated cardiomyopathy	0.00879	0.00879	CcSEcCtD
Tobramycin—Cough increased—Lisinopril—dilated cardiomyopathy	0.00876	0.00876	CcSEcCtD
Tobramycin—Oliguria—Lisinopril—dilated cardiomyopathy	0.0087	0.0087	CcSEcCtD
Tobramycin—Deafness—Furosemide—dilated cardiomyopathy	0.00867	0.00867	CcSEcCtD
Tobramycin—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00864	0.00864	CcSEcCtD
Tobramycin—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00853	0.00853	CcSEcCtD
Tobramycin—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00842	0.00842	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00822	0.00822	CcSEcCtD
Tobramycin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00797	0.00797	CcSEcCtD
Tobramycin—Lethargy—Furosemide—dilated cardiomyopathy	0.00791	0.00791	CcSEcCtD
Tobramycin—Wheezing—Lisinopril—dilated cardiomyopathy	0.00779	0.00779	CcSEcCtD
Tobramycin—Malaise—Spironolactone—dilated cardiomyopathy	0.00774	0.00774	CcSEcCtD
Tobramycin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00768	0.00768	CcSEcCtD
Tobramycin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00727	0.00727	CcSEcCtD
Tobramycin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00722	0.00722	CcSEcCtD
Tobramycin—Dehydration—Furosemide—dilated cardiomyopathy	0.00721	0.00721	CcSEcCtD
Tobramycin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00706	0.00706	CcSEcCtD
Tobramycin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00706	0.00706	CcSEcCtD
Tobramycin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00701	0.00701	CcSEcCtD
Tobramycin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00686	0.00686	CcSEcCtD
Tobramycin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00684	0.00684	CcSEcCtD
Tobramycin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00664	0.00664	CcSEcCtD
Tobramycin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00639	0.00639	CcSEcCtD
Tobramycin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.0063	0.0063	CcSEcCtD
Tobramycin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00611	0.00611	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00605	0.00605	CcSEcCtD
Tobramycin—Renal failure—Furosemide—dilated cardiomyopathy	0.00588	0.00588	CcSEcCtD
Tobramycin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00577	0.00577	CcSEcCtD
Tobramycin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00558	0.00558	CcSEcCtD
Tobramycin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00557	0.00557	CcSEcCtD
Tobramycin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00554	0.00554	CcSEcCtD
Tobramycin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00545	0.00545	CcSEcCtD
Tobramycin—Dehydration—Lisinopril—dilated cardiomyopathy	0.00541	0.00541	CcSEcCtD
Tobramycin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.0053	0.0053	CcSEcCtD
Tobramycin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00526	0.00526	CcSEcCtD
Tobramycin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00517	0.00517	CcSEcCtD
Tobramycin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00516	0.00516	CcSEcCtD
Tobramycin—Asthma—Lisinopril—dilated cardiomyopathy	0.00503	0.00503	CcSEcCtD
Tobramycin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00501	0.00501	CcSEcCtD
Tobramycin—Tinnitus—Furosemide—dilated cardiomyopathy	0.005	0.005	CcSEcCtD
Tobramycin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00498	0.00498	CcSEcCtD
Tobramycin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00496	0.00496	CcSEcCtD
Tobramycin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00495	0.00495	CcSEcCtD
Tobramycin—Angiopathy—Furosemide—dilated cardiomyopathy	0.00487	0.00487	CcSEcCtD
Tobramycin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00485	0.00485	CcSEcCtD
Tobramycin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Tobramycin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00479	0.00479	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00467	0.00467	CcSEcCtD
Tobramycin—Erythema—Furosemide—dilated cardiomyopathy	0.00467	0.00467	CcSEcCtD
Tobramycin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00463	0.00463	CcSEcCtD
Tobramycin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00457	0.00457	CcSEcCtD
Tobramycin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00455	0.00455	CcSEcCtD
Tobramycin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00445	0.00445	CcSEcCtD
Tobramycin—Rash—Spironolactone—dilated cardiomyopathy	0.00442	0.00442	CcSEcCtD
Tobramycin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00441	0.00441	CcSEcCtD
Tobramycin—Renal failure—Lisinopril—dilated cardiomyopathy	0.00441	0.00441	CcSEcCtD
Tobramycin—Vision blurred—Furosemide—dilated cardiomyopathy	0.0044	0.0044	CcSEcCtD
Tobramycin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0044	0.0044	CcSEcCtD
Tobramycin—Headache—Spironolactone—dilated cardiomyopathy	0.00439	0.00439	CcSEcCtD
Tobramycin—Anaemia—Furosemide—dilated cardiomyopathy	0.00432	0.00432	CcSEcCtD
Tobramycin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00423	0.00423	CcSEcCtD
Tobramycin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00421	0.00421	CcSEcCtD
Tobramycin—Vertigo—Furosemide—dilated cardiomyopathy	0.0042	0.0042	CcSEcCtD
Tobramycin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00419	0.00419	CcSEcCtD
Tobramycin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00418	0.00418	CcSEcCtD
Tobramycin—Nausea—Spironolactone—dilated cardiomyopathy	0.00416	0.00416	CcSEcCtD
Tobramycin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00404	0.00404	CcSEcCtD
Tobramycin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.004	0.004	CcSEcCtD
Tobramycin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00398	0.00398	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00395	0.00395	CcSEcCtD
Tobramycin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00395	0.00395	CcSEcCtD
Tobramycin—Confusional state—Furosemide—dilated cardiomyopathy	0.00384	0.00384	CcSEcCtD
Tobramycin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00381	0.00381	CcSEcCtD
Tobramycin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00375	0.00375	CcSEcCtD
Tobramycin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00374	0.00374	CcSEcCtD
Tobramycin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00373	0.00373	CcSEcCtD
Tobramycin—Skin disorder—Furosemide—dilated cardiomyopathy	0.0037	0.0037	CcSEcCtD
Tobramycin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00365	0.00365	CcSEcCtD
Tobramycin—Anorexia—Furosemide—dilated cardiomyopathy	0.00363	0.00363	CcSEcCtD
Tobramycin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00363	0.00363	CcSEcCtD
Tobramycin—Erythema—Lisinopril—dilated cardiomyopathy	0.0035	0.0035	CcSEcCtD
Tobramycin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00343	0.00343	CcSEcCtD
Tobramycin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00342	0.00342	CcSEcCtD
Tobramycin—Back pain—Lisinopril—dilated cardiomyopathy	0.00339	0.00339	CcSEcCtD
Tobramycin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00331	0.00331	CcSEcCtD
Tobramycin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.0033	0.0033	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00329	0.00329	CcSEcCtD
Tobramycin—Pain—Furosemide—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Tobramycin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00325	0.00325	CcSEcCtD
Tobramycin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00324	0.00324	CcSEcCtD
Tobramycin—Angioedema—Lisinopril—dilated cardiomyopathy	0.0032	0.0032	CcSEcCtD
Tobramycin—Malaise—Lisinopril—dilated cardiomyopathy	0.00316	0.00316	CcSEcCtD
Tobramycin—Vertigo—Lisinopril—dilated cardiomyopathy	0.00315	0.00315	CcSEcCtD
Tobramycin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00314	0.00314	CcSEcCtD
Tobramycin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00314	0.00314	CcSEcCtD
Tobramycin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00312	0.00312	CcSEcCtD
Tobramycin—Cough—Lisinopril—dilated cardiomyopathy	0.00306	0.00306	CcSEcCtD
Tobramycin—Urticaria—Furosemide—dilated cardiomyopathy	0.00303	0.00303	CcSEcCtD
Tobramycin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00301	0.00301	CcSEcCtD
Tobramycin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00301	0.00301	CcSEcCtD
Tobramycin—Myalgia—Lisinopril—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Tobramycin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00296	0.00296	CcSEcCtD
Tobramycin—Discomfort—Lisinopril—dilated cardiomyopathy	0.00295	0.00295	CcSEcCtD
Tobramycin—Confusional state—Lisinopril—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Tobramycin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00286	0.00286	CcSEcCtD
Tobramycin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00281	0.00281	CcSEcCtD
Tobramycin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Tobramycin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00278	0.00278	CcSEcCtD
Tobramycin—Asthenia—Furosemide—dilated cardiomyopathy	0.00274	0.00274	CcSEcCtD
Tobramycin—Anorexia—Lisinopril—dilated cardiomyopathy	0.00273	0.00273	CcSEcCtD
Tobramycin—Pruritus—Furosemide—dilated cardiomyopathy	0.0027	0.0027	CcSEcCtD
Tobramycin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00261	0.00261	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00261	0.00261	CcSEcCtD
Tobramycin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00257	0.00257	CcSEcCtD
Tobramycin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00255	0.00255	CcSEcCtD
Tobramycin—Dizziness—Furosemide—dilated cardiomyopathy	0.00252	0.00252	CcSEcCtD
Tobramycin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00249	0.00249	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00247	0.00247	CcSEcCtD
Tobramycin—Pain—Lisinopril—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Tobramycin—Vomiting—Furosemide—dilated cardiomyopathy	0.00242	0.00242	CcSEcCtD
Tobramycin—Rash—Furosemide—dilated cardiomyopathy	0.0024	0.0024	CcSEcCtD
Tobramycin—Dermatitis—Furosemide—dilated cardiomyopathy	0.0024	0.0024	CcSEcCtD
Tobramycin—Headache—Furosemide—dilated cardiomyopathy	0.00239	0.00239	CcSEcCtD
Tobramycin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00236	0.00236	CcSEcCtD
Tobramycin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00234	0.00234	CcSEcCtD
Tobramycin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00227	0.00227	CcSEcCtD
Tobramycin—Nausea—Furosemide—dilated cardiomyopathy	0.00226	0.00226	CcSEcCtD
Tobramycin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00226	0.00226	CcSEcCtD
Tobramycin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00226	0.00226	CcSEcCtD
Tobramycin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00211	0.00211	CcSEcCtD
Tobramycin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Tobramycin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00202	0.00202	CcSEcCtD
Tobramycin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00196	0.00196	CcSEcCtD
Tobramycin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00189	0.00189	CcSEcCtD
Tobramycin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00182	0.00182	CcSEcCtD
Tobramycin—Rash—Lisinopril—dilated cardiomyopathy	0.0018	0.0018	CcSEcCtD
Tobramycin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0018	0.0018	CcSEcCtD
Tobramycin—Headache—Lisinopril—dilated cardiomyopathy	0.00179	0.00179	CcSEcCtD
Tobramycin—Nausea—Lisinopril—dilated cardiomyopathy	0.0017	0.0017	CcSEcCtD
